Eric Routhier - Publications

Affiliations: 
Analytic Technologies Eisai, Inc., Andover, MA, United States 

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2010 Drozdowski B, Zhou Y, Kline B, Spidel J, Chan YY, Albone E, Turchin H, Chao Q, Henry M, Balogach J, Routhier E, Bavari S, Nicolaides NC, Sass PM, Grasso L. Generation and characterization of high affinity human monoclonal antibodies that neutralize staphylococcal enterotoxin B. Journal of Immune Based Therapies and Vaccines. 8: 9. PMID 21176153 DOI: 10.1186/1476-8518-8-9  0.342
2007 Tomkowicz B, Rybinski K, Foley B, Ebel W, Kline B, Routhier E, Sass P, Nicolaides NC, Grasso L, Zhou Y. Interaction of endosialin/TEM1 with extracellular matrix proteins mediates cell adhesion and migration. Proceedings of the National Academy of Sciences of the United States of America. 104: 17965-70. PMID 17986615 DOI: 10.1073/Pnas.0705647104  0.316
2006 Li J, Sai T, Berger M, Chao Q, Davidson D, Deshmukh G, Drozdowski B, Ebel W, Harley S, Henry M, Jacob S, Kline B, Lazo E, Rotella F, Routhier E, et al. Human antibodies for immunotherapy development generated via a human B cell hybridoma technology. Proceedings of the National Academy of Sciences of the United States of America. 103: 3557-62. PMID 16505368 DOI: 10.1073/Pnas.0511285103  0.387
2006 Li J, Sai T, Berger M, Chao Q, Davidson D, Deshmukh G, Drozdowski B, Ebel W, Harley S, Henry M, Jacob S, Kline B, Lazo E, Rotella F, Rudolf K, ... Routhier E, et al. Su.99. Human Antibodies for Immunotherapy Development Generated Via a Human B-Cell Hybridoma Technology Clinical Immunology. 119. DOI: 10.1016/J.Clim.2006.04.526  0.324
2005 Nicolaides NC, Ebel W, Kline B, Chao Q, Routhier E, Sass PM, Grasso L. Morphogenics as a tool for target discovery and drug development. Annals of the New York Academy of Sciences. 1059: 86-96. PMID 16382047 DOI: 10.1196/Annals.1339.029  0.374
2003 Routhier EL, Donover PS, Prendergast GC. hob1+, the fission yeast homolog of Bin1, is dispensable for endocytosis or actin organization, but required for the response to starvation or genotoxic stress. Oncogene. 22: 637-48. PMID 12569356 DOI: 10.1038/sj.onc.1206162  0.524
2001 Routhier EL, Burn TC, Abbaszade I, Summers M, Albright CF, Prendergast GC. Human BIN3 complements the F-actin localization defects caused by loss of Hob3p, the fission yeast homolog of Rvs161p. The Journal of Biological Chemistry. 276: 21670-7. PMID 11274158 DOI: 10.1074/Jbc.M101096200  0.388
Show low-probability matches.